ACADIA Pharmaceuticals Inc (ACAD)

Operating return on assets (Operating ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	230,794	112,235	22,815	-4,585	-73,379	-154,386	-127,476	-164,164	-223,596	-222,190	-206,625	-216,683	-170,439	-192,944	-263,542	-263,843	-286,586	-275,823	-235,345	-248,426
Total assets	US$ in thousands	1,187,760	976,868	914,099	855,103	748,956	632,540	642,769	655,305	587,812	602,491	612,766	624,251	700,122	717,673	724,429	755,173	782,616	795,664	759,649	747,450
Operating ROA		19.43%	11.49%	2.50%	-0.54%	-9.80%	-24.41%	-19.83%	-25.05%	-38.04%	-36.88%	-33.72%	-34.71%	-24.34%	-26.88%	-36.38%	-34.94%	-36.62%	-34.67%	-30.98%	-33.24%

December 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $230,794K ÷ $1,187,760K
= 19.43%

Operating ROA measures a company's ability to generate profits from its operational activities relative to its total assets.

For ACADIA Pharmaceuticals Inc, the trend in operating ROA shows significant fluctuations over the quarters. The ratios were consistently negative until the first quarter of 2024. It is notable that the company was generating losses relative to its total assets from March 2020 to June 2024.

However, a turnaround was observed in the following periods, with the operating ROA turning positive in the second quarter of 2024 and showing a continued improvement through the end of the year. The rise in the operating ROA indicates that the company's operational efficiency and profitability from its assets improved significantly during this period.

It would be important to monitor future quarters to assess whether this positive trend is sustainable and if the company can continue to effectively utilize its assets to generate profits.